Tumor BRCA1, RRM1 and RRM2 mRNA Expression Levels and Clinical Response to First-Line Gemcitabine plus Docetaxel in Non-Small-Cell Lung Cancer Patients

BACKGROUND: Overexpression of RRM1 and RRM2 has been associated with gemcitabine resistance. BRCA1 overexpression increases sensitivity to paclitaxel and docetaxel. We have retrospectively examined the effect of RRM1, RRM2 and BRCA1 expression on outcome to gemcitabine plus docetaxel in advanced non...

Descripción completa

Detalles Bibliográficos
Autores principales: Boukovinas, Ioannis, Papadaki, Chara, Mendez, Pedro, Taron, Miquel, Mavroudis, Dimitris, Koutsopoulos, Anastasios, Sanchez-Ronco, Maria, Sanchez, Jose Javier, Trypaki, Maria, Staphopoulos, Eustathios, Georgoulias, Vassilis, Rosell, Rafael, Souglakos, John
Formato: Texto
Lenguaje:English
Publicado: Public Library of Science 2008
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2579656/
https://www.ncbi.nlm.nih.gov/pubmed/19002265
http://dx.doi.org/10.1371/journal.pone.0003695

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2579656/
https://www.ncbi.nlm.nih.gov/pubmed/19002265
http://dx.doi.org/10.1371/journal.pone.0003695

Ejemplares similares